lMEDICINAL FORMS
There can be variation in the licensing of different medicines
containing the same drug.
Ear/eye/nose drops solution
EXCIPIENTS:May contain Benzalkonium chloride, disodium edetate
▶Betnesol-N(RPH Pharmaceuticals AB)
Betamethasone (as Betamethasone sodium phosphate) 1 mg per
1 ml, Neomycin sulfate 5 mg per 1 mlBetnesol-N ear/eye/nose
drops| 10 mlP£ 2. 39 DT = £ 2. 39
Dexamethasone with framycetin
sulfate and gramicidin 21-Dec-2017
The properties listed below are those particular to the
combination only. For the properties of the components
please consider, dexamethasone p. 668.
lINDICATIONS AND DOSE
Local treatment of inflammation (short-term)
▶TO THE EYE
▶Child:Apply 4 – 6 times a day, may be administered
every 30 – 60 minutes in severe conditions until
controlled, then reduce frequency
IMPORTANT SAFETY INFORMATION
MHRA/CHM ADVICE: CORTICOSTEROIDS: RARE RISK OF CENTRAL
SEROUS CHORIORETINOPATHY WITH LOCAL AS WELL AS SYSTEMIC
ADMINISTRATION (AUGUST 2017)
See Corticosteroids, general use p. 434.
lINTERACTIONS→Appendix 1 : corticosteroids
lLESS SUITABLE FOR PRESCRIBINGSofradex®is less
suitable for prescribing.
lMEDICINAL FORMS
There can be variation in the licensing of different medicines
containing the same drug.
Ear/eye drops solution
EXCIPIENTS:May contain Polysorbates
▶Sofradex(Sanofi)
Gramicidin 50 microgram per 1 ml, Dexamethasone (as
Dexamethasone sodium metasulfobenzoate) 500 microgram per
1 ml, Framycetin sulfate 5 mg per 1 mlSofradex ear/eye drops|
8 mlP£ 7. 50
Dexamethasone with hypromellose,
neomycin and polymyxin B sulfate
The properties listed below are those particular to the
combination only. For the properties of the components
please consider, dexamethasone p. 668.
lINDICATIONS AND DOSE
Local treatment of inflammation (short-term)
▶TO THE EYE USING EYE DROP
▶Child:Apply every 30 – 60 minutes until controlled,
then reduced to 4 – 6 times a day
Local treatment of inflammation (short-term)
▶TO THE EYE USING EYE OINTMENT
▶Child:Apply 3 – 4 times a day, alternatively, apply at
night when used with eye drops
lINTERACTIONS→Appendix 1 : corticosteroids.neomycin
lLESS SUITABLE FOR PRESCRIBINGDexamethasone with
neomycin and polymixin B sulfate is less suitable for
prescribing.
lMEDICINAL FORMS
There can be variation in the licensing of different medicines
containing the same drug.
Eye ointment
EXCIPIENTS:May contain Hydroxybenzoates (parabens), woolfat and
related substances (including lanolin)
▶Maxitrol(Novartis Pharmaceuticals UK Ltd)
Dexamethasone 1 mg per 1 gram, Neomycin (as Neomycin
sulfate) 3500 unit per 1 gram, Polymyxin B sulfate 6000 unit per
1 gramMaxitrol eye ointment| 3. 5 gramP£ 1. 44
Eye drops
EXCIPIENTS:May contain Benzalkonium chloride, polysorbates
▶Maxitrol(Novartis Pharmaceuticals UK Ltd)
Dexamethasone 1 mg per 1 ml, Hypromellose 5 mg per 1 ml,
Neomycin (as Neomycin sulfate) 3500 unit per 1 ml, Polymyxin B
sulfate 6000 unit per 1 mlMaxitrol eye drops|^5 mlP£^1.^68
1.2a Anterior uveitis
ANTIMUSCARINICS
Antimuscarinics (eye) f
lCAUTIONSChildren under 3 months owing to the possible
association between cycloplegia and the development of
amblyopia.darkly pigmented iris is more resistant to
pupillary dilatation and caution should be exercised to
avoid overdosage.mydriasis can precipitate acute angle-
closure glaucoma (usually in those who are predisposed to
the condition because of a shallow anterior chamber).
neonates at increased risk of systemic toxicity
lSIDE-EFFECTSArrhythmias.conjunctivitis (on prolonged
administration).dry mouth.dry skin.eye oedema (on
prolonged administration.flushing.hyperaemia (on
prolonged administration).gastrointestinal disorders.
urinary disorders
lPATIENT AND CARER ADVICEPatients may not be able to
undertake skilled tasks until vision clears after mydriasis.
eiiiiFabove
Atropine sulfate
lINDICATIONS AND DOSE
Cycloplegia
▶TO THE EYE USING EYE DROP
▶Child 3 months–17 years:Apply twice daily for 3 days,
before procedure
Anterior uveitis
▶TO THE EYE USING EYE DROP
▶Child 2–17 years:Apply 1 drop up to 4 times a day
lUNLICENSED USENot licensed for use in children for
uveitis.
lINTERACTIONS→Appendix 1 : atropine
lSIDE-EFFECTS
SIDE-EFFECTS, FURTHER INFORMATIONSystemic side-
effects can occur.
lPRESCRIBING AND DISPENSING INFORMATIONAlthough
multi-dose atropine sulphate eye drops commonly contain
preservatives, preservative-free unit dose vials may be
available.
lMEDICINAL FORMS
There can be variation in the licensing of different medicines
containing the same drug. Forms available from special-order
manufacturers include: eye drops
Eye drops
▶Atropine sulfate (Non-proprietary)
Atropine sulfate 10 mg per 1 mlAtropine 1 % eye drops|
10 mlP£ 132. 25 DT = £ 132. 25
670 Allergic and inflammatory eye conditions BNFC 2018 – 2019
Eye
11